|
|
 |
|
Viewing report
|
|
|
|
The Future of R&D Outsourcing: Investigating Development Hurdles, Key Challenges & Strategies to Optimize CRO Relationships
Business Insights, Jan 2010, Pages: 158
For several years, drug developers have been under intense pressure to introduce new products in an environment of escalating R&D costs, blockbuster patent expiration and resulting generic competition, increasingly complex science, heightened regulatory scrutiny, and other pressures. The global economic meltdown has exacerbated these challenges with new R&D staff and budget reductions. In order to remain competitive, drug makers must now do more with less. Outsourcing, particularly to low cost offshore venues like India and China, offers a means to maintain productivity within new cost parameters.
However, while some drug makers have optimized their R&D outsourcing methodologies and have developed sophisticated processes to select, monitor and manage a wide range of projects, many other R&D outsourcing projects fail due to poor planning on the part of sponsors. A large proportion of these failures could be averted as many of the most common reasons for failure are preventable problems relating to R&D outsourcing strategy, supplier evaluation & selection, contracting, project organization and expectations, supplier management, culture, staff turnover and intellectual property.
Key features of this report
- Discussion of the factors leading to current imperatives to increased outsourced R&D.
- Detailed descriptions of both effective and ineffective R&D outsourcing approaches.
- In depth analysis of the types of different R&D outsourcing relationships, their advantages and disadvantages.
- 5 case studies that illustrate R&D outsourcing best practices.
- Comprehensive discussion of offshore R&D outsourcing, particularly focusing on India and China.
Scope of this report
- Understand the driving forces behind R&D outsourcing.
- Save time and money with the report’s succinct compilation and analysis of current R&D outsourcing trends.
- Learn how R&D outsourcing will evolve over the next several years and why.
- Assess your competitive position vis-à-vis other drug makers and learn about R&D outsourcing best practices via detailed case studies.
Key Market Issues
- Although cost cutting has previously not been a concern for R&D departments, the current economic environment has brought expense reduction programs into research labs. Most of the leading drug makers have recently undertaken and/or are currently in the midst of broad R&D cost cutting programs
- Because drug makers must continue to introduce new products, maintaining high productivity is key. R&D outsourcing offers a means to achieve this, particularly via low cost offshore outsourcing.
- Most R&D outsourcing programs do not focus on a single approach but include several different types of relationships with contractors. The savviest drug makers combine these approaches in a well thought-out, synergistic manner while many others will implement them in a slipshod, ineffective fashion that results in high project failure rates.
Key findings from this report
- Usage of CROs will rise by 9.9% annually through 2014 with the greatest growth in Phase IIIb and IV testing at 13.8% per year.
- While the top 10 CROs account for more than half of all R&D outsourcing, more than 1,000 others comprise the remaining 44%.
- Offshore outsourcing, particularly to India and China, offers cost savings of 30% to 60% compared to the US and Western Europe.
- The 100 Indian CROs tend to be larger and more focused on clinical trials while the 300 Chinese CROs are smaller and many are building strong pre-clinical capabilities.
Key questions answered
- Why is R&D outsourcing rising?
- Which types of R&D outsourcing approaches are currently most common?
- Which forms of R&D cost cutting will increase most in the future?
Customers who bought this item also bought
The CRO Market Outlook: Emerging Markets, Leading Players and Future Trends
Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs
U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade
Outsourcing Technology in Asia--Analysis of the Changing Face of R&D (Technical Insights)
Clinical Trial Patient Recruitment: Accelerate Enrollment, Increase Retention and Reduce Costs
Report on Chinese Service Outsourcing Industry, 2011-2012
Business Process Outsourcing (BPO) - Global Strategic Business Report
Call Centers - Global Strategic Business Report
Legal Services - Global Outlook
Competing in the U.S. Contract Research Market
|
|
|
|
